Stock Scorecard
Stock Summary for Arrowhead Pharmaceuticals Inc (ARWR) - $13.70 as of 3/28/2025 7:15:44 PM EST
Total Score
7 out of 30
Safety Score
34 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ARWR
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ARWR
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ARWR
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ARWR
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ARWR (34 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ARWR
Financial Details for ARWR
Company Overview |
|
|---|---|
| Ticker | ARWR |
| Company Name | Arrowhead Pharmaceuticals Inc |
| Country | USA |
| Description | Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California. |
| Sector Name | TRADE & SERVICES |
| Industry Name | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 5/7/2025 |
Stock Price History |
|
| Last Day Price | 13.70 |
| Price 4 Years Ago | 66.30 |
| Last Day Price Updated | 3/28/2025 7:15:44 PM EST |
| Last Day Volume | 1,437,240 |
| Average Daily Volume | 1,511,644 |
| 52-Week High | 30.41 |
| 52-Week Low | 13.68 |
| Last Price to 52 Week Low | 0.15% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 158.27 |
| Sector PE | 49.43 |
| 5-Year Average PE | -19.39 |
| Free Cash Flow Ratio | 3.77 |
| Industry Free Cash Flow Ratio | 23.46 |
| Sector Free Cash Flow Ratio | 86.57 |
| Current Ratio Most Recent Quarter | 6.09 |
| Total Cash Per Share | 3.63 |
| Book Value Per Share Most Recent Quarter | 0.42 |
| Price to Book Ratio | 36.03 |
| Industry Price to Book Ratio | 5.00 |
| Sector Price to Book Ratio | 8.93 |
| Price to Sales Ratio Twelve Trailing Months | 765.13 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.86 |
| Sector Price to Sales Ratio Twelve Trailing Months | 1.97 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 137,317,000 |
| Market Capitalization | 1,881,242,900 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.59% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 9.80% |
| Annual Earnings Growth | -192.04% |
| Reported EPS 12 Trailing Months | -5.10 |
| Reported EPS Past Year | -1.39 |
| Reported EPS Prior Year | -5.01 |
| Net Income Twelve Trailing Months | -639,714,000 |
| Net Income Past Year | -599,493,000 |
| Net Income Prior Year | -205,275,000 |
| Quarterly Revenue Growth YOY | -29.60% |
| 5-Year Revenue Growth | -54.01% |
| Operating Margin Twelve Trailing Months | -6,456.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 499,046,000 |
| Total Cash Past Year | 578,276,000 |
| Total Cash Prior Year | 292,700,000 |
| Net Cash Position Most Recent Quarter | 89,632,000 |
| Net Cash Position Past Year | 185,093,000 |
| Long Term Debt Past Year | 393,183,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 409,414,000 |
| Equity to Debt Ratio Past Year | 0.32 |
| Equity to Debt Ratio Most Recent Quarter | 0.11 |
| Total Stockholder Equity Past Year | 185,444,000 |
| Total Stockholder Equity Prior Year | 271,343,000 |
| Total Stockholder Equity Most Recent Quarter | 52,589,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -571,612,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -4.16 |
| Free Cash Flow Past Year | -604,320,000 |
| Free Cash Flow Prior Year | -330,627,000 |
Options |
|
| Put/Call Ratio | 0.81 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.12 |
| MACD Signal | -1.09 |
| 20-Day Bollinger Lower Band | 13.83 |
| 20-Day Bollinger Middle Band | 19.27 |
| 20-Day Bollinger Upper Band | 24.72 |
| Beta | 0.92 |
| RSI | 30.85 |
| 50-Day SMA | 21.95 |
| 150-Day SMA | 29.06 |
| 200-Day SMA | 37.08 |
System |
|
| Modified | 3/28/2025 5:58:52 PM EST |